Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune mechanisms and tumor dormancy

T H Stewart1

  • 1Ottawa General Hospital, Ontario, Canada.

Medicina
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Tumor dormancy, a state where cancer cells remain inactive, is naturally maintained by the immune system. Reactivation of dormant cancer cells, like non-small cell lung cancer, is often linked to immune suppression.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Cold" white kidney.

Canadian Medical Association journal·2010
Same author

Organization of efferent neurons in area 19: the projection to extrastriate area 21a.

Brain research·2000
Same author

The projection from V1 to extrastriate area 21a: a second patchy efferent pathway colocalizes with the CO blob columns in cat visual cortex.

Cerebral cortex (New York, N.Y. : 1991)·2000
Same author

Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus.

British journal of cancer·2000
Same author

Immunological enhancement of breast cancer.

Parasitology·1997
Same author

Evidence for immune facilitation of breast cancer growth and for the immune promotion of oncogenesis in breast cancer.

Medicina·1996

Area of Science:

  • Oncology
  • Immunology
  • Cancer Biology

Background:

  • Tumor dormancy is a natural phenomenon observed in cancer patients.
  • It is believed to be maintained by immune surveillance mechanisms.
  • Microscopic metastases can remain dormant after initial treatment.